M Dialysis AB

M Dialysis AB is a Swedish medical device and research company, founded in 2011. The company's slogan, "Our mission is to make microdialysis a world wide routine monitoring technique," articulates its dedication to advancing healthcare. M Dialysis specializes in biotechnology, health care, and medical devices, developing and marketing clinical microdialysis solutions for advanced clinical research and general intensive care usage. The firm's unique and market-leading solutions are developed, produced, and sold to clinicians and researchers globally with the aim of optimizing patient care and accelerating drug development. With products manufactured in Sweden under ISO 13485 and according to FDA standards, the company maintains a high level of quality control and compliance. M Dialysis offers a complete line of microdialysis instruments, consumables, and computer software, catering to universities, hospitals, and pharmaceutical companies as unique tools for in vivo sampling and monitoring of organs and tissues. M Dialysis's core competence lies within solutions based on the Microdialysis technique. The company further diversifies its offerings by developing, producing, and marketing tissue monitoring solutions for neuro and reconstructive surgery. Additionally, it provides clinical research solutions for numerous other applications such as gastrointestinal, hepatic, muscle, and skin. The company's product portfolio is primarily based on the ISCUS platform and a broad range of tissue catheters. Operating from Stockholm, Sweden, the company also has a subsidiary north of Boston, USA. Despite not having information on its last investment or investors, M Dialysis AB's dedication to advancing microdialysis as a routine monitoring technique positions it as an innovative player in the healthcare technology space.